Clinical trial
Treatment of Wounds Using Oasis® Extracellular Matrix in the Community Setting
NCT03632031 is registered in ClinicalTrials.gov with Cook Biotech Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Wounds Using Oasis® Extracellular Matrix in the Community Setting
- Lead sponsor
- Cook Biotech Incorporated
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- September 26, 2025
- Enrollment
- 41 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
non-healing wound